Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
p acnes corneal ulcer endopthalmitis kaposi esotropia intraocular uveitis optic neuritis anisocoria retinitisYour Article Summary
See Latest ArticlesRepeated intravitreal bevacizumab (Avastin) treatment of persistent new vessels in proliferative diabetic retinopathy after complete panretinal photocoagulation
Acta Ophthalmologica, 09/17/09
Schmidinger G et al. – Intravitreal bevacizumab led to a significant reduction of retinal new vessels for a mean period of 2.9 months. A 3–monthly retreatment regime might be a valid method to control retinal new vessels in diabetic patients with persistent new vessels.
Related Articles
Retinopathy - screening recommendations
Australian Family Physician, 10/06/09
Relevance Score: 92%
Identification of independent risk factors for the development of diabetic retinopathy requiring treatment
Acta Ophthalmologica, 11/18/09
Relevance Score: 89%
Glyceraldehyde 3 phosphate dehydrogenase in retinal microvasculature: Implications for the development and progression of diabetic retinopathy
Investigative Ophthalmology and Visual Science, 11/18/09
Relevance Score: 88%
Prevalence and Severity of Hypertensive Retinopathy in Children
Clinical Pediatrics, 10/22/09
Relevance Score: 88%
Diabetic Retinopathy Screening Update
Clinical Diabetes, 10/19/09
Relevance Score: 88%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Risk of Endophthalmitis After Intravitreal Drug Injection When Topical Antibiotics Are Not Required
Archives of Ophthalmology, 12/18/09
Comparing intravitreal triamcinolone acetonide and bevacizumab injections for the treatment of diabetic macular oedema: a randomized double-blind study
Acta Ophthalmologica, 12/18/09
Pre-Treatment with Intravitreal Triamcinolone Prior to Laser for Diabetic Macular Edema: 6-Month Results of a Randomised, Placebo-Controlled Trial
Investigative Ophthalmology and Visual Science, 12/18/09
Today in Retina...keeping you current
Receive free subspecialty "5-minute updates" via email
Comparing intravitreal triamcinolone acetonide and bevacizumab injections for the treatment of diabetic macular oedema: a randomized double-blind study
Acta Ophthalmologica, 12/18/09
Pre-Treatment with Intravitreal Triamcinolone Prior to Laser for Diabetic Macular Edema: 6-Month Results of a Randomised, Placebo-Controlled Trial
Investigative Ophthalmology and Visual Science, 12/18/09
Adverse Events After Pars Plana Vitrectomy Among Medicare Beneficiaries
Archives of Ophthalmology, 12/18/09
Article Search
Sponsor